性别间动脉解剖差异不影响慢性肠系膜缺血血管内干预后的主要通畅率
本研究回顾性分析了2003至2020年间单中心因慢性肠系膜缺血行肠系膜上动脉支架置入的182例患者,女性占69.8%。女性肠系膜上动脉原生直径及近端扩张直径均显著小于男性,但主要通畅率丢失与血管直径无关,男性性别与主要通畅率丢失风险增加相关。
要点
- 女性肠系膜上动脉原生直径和近端扩张直径显著小于男性。
- 血管直径与主要通畅率丢失无显著独立关联。
- 男性性别与主要通畅率丢失风险增加独立相关。
核心结论
- 女性肠系膜上动脉直径显著小于男性,但主要通畅率丢失与血管直径无关。
- 男性性别与主要通畅率丢失风险增加独立相关,提示技术因素可能抵消血管直径的影响。
研究设计与样本
- 回顾性队列研究,纳入2003至2020年单中心因慢性肠系膜缺血行肠系膜上动脉支架置入的182例患者。
- 按自我认同性别分层,比较肠系膜上动脉解剖测量指标及主要通畅率,并采用多变量Cox比例风险模型分析解剖预测因素。
主要发现
- 女性肠系膜上动脉原生直径显著小于男性(5.2 mm vs. 6.9 mm;P < 0.001)。
- 女性近端扩张直径显著小于男性(10.4 mm vs. 13.5 mm;P < 0.001)。
- 病变长度及扩张直径与原生直径比值在性别间无差异。
- 多变量分析中,较大扩张直径(HR 0.97,95%CI 0.89–1.07;P = 0.59)和较大原生直径(HR 0.88,95%CI 0.71–1.08;P = 0.22)与主要通畅率丢失降低呈趋势但无统计学显著性。
- 男性性别与主要通畅率丢失风险增加相关(HR 3.07,95%CI 1.18–7.96;P = 0.024)。
关键数值与推荐
- 女性肱动脉入路相关并发症发生率17.1%,男性6.4%(P = 0.075)。
临床怎么用
- 临床中不应仅因女性肠系膜上动脉直径较小而担心主要通畅率变差。
- 男性患者术后可能需更密切监测主要通畅率丢失。
- 技术因素如完整覆盖病变可能有助于抵消血管直径的影响。
局限性
- 回顾性单中心设计可能限制结论外推。
- 样本量及事件数有限,统计效能可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sex-based differences in patency outcomes attributed to artery size have been observed in peripheral artery disease studies. However, variation in the superior mesenteric artery (SMA) dimensions between genders in the chronic mesenteric ischemia (CMI) population is not well documented. This study aimed to compare the anatomical characteristics of SMA and assess patency outcomes between sexes in patients with CMI. METHODS: A retrospective review of all patients who underwent SMA stenting for CMI at a single quaternary center from 2003 to 2020 was conducted. The cohort was stratified according to self-identified gender. Anatomical SMA measurements, such as native diameter (ND) and length of the atherosclerotic lesion (LL), and procedural SMA measurements, such as proximal flare diameter (FD) and FD-to-ND ratio, were reviewed. FD was defined as the maximal postdilatation stent diameter at the SMA orifice. Multivariable Cox proportional hazard models were also conducted to evaluate anatomic predictors for primary patency loss. RESULTS: A total of 182 patients were included. The overall mean age was 71 years, and 69.8% were women. No significant difference in comorbidities was found between female and male patients. Technical success was achieved in all cases, and 94% had complete resolution of presenting symptoms with no discrepancy between sexes. SMA measurements demonstrated a significantly smaller ND in the female compared to the male cohort (5.2 mm vs. 6.9 mm; P < 0.001). FD was smaller in the female compared to the male cohort (10.4 mm vs. 13.5 mm; P < 0.001). No difference was found in the LL or FD-to-ND ratio between cohorts. In multivariable analyses, greater FD (hazard ratio [HR] 0.97, 95% confidence interval [CI] 0.89, 1.07; P = 0.59) and larger ND (HR 0.88, 95% CI 0.71, 1.08; P = 0.22) trended toward lower primary patency loss without statistical significance. LL and FD-to-ND ratio were not independently associated with patency outcomes. Male sex was associated with an increased risk of primary patency loss (HR 3.07, 95% CI 1.18, 7.96; P = 0.024). Brachial access-related complications were more commonly seen in the female cohort (17.1%, 6.4%, P = 0.075). CONCLUSION: In a large population treated for CMI, we observed a statistically significantly smaller SMA diameter in the female cohort. No difference in primary patency loss was observed with vessel diameter. Male sex was associated with an increased risk of primary patency loss. This finding suggests that technical considerations, such as complete lesion coverage, may offset the impact of vessel diameter.
引用
- Khan A, Damara FA, Sorour AA, et al. Sex-Based Differences in Arterial Anatomy Do Not Affect Primary Patency after Endovascular Intervention for Chronic Mesenteric Ischemia. Ann Vasc Surg. 2026. PMID: 42526752. doi:10.1016/j.avsg.2026.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。